Some advanced lung cancer patients benefit from immunotherapy even after the disease has progressed as evaluated by standard criteria, according to research presented at the European Lung Cancer Conference (ELCC).1 The findings pave the way for certain patients to continue treatment if the disease is not progressing according to new, more specific, criteria. The Response Evaluation...
Tag: <span>Lung cancer</span>
Post
Researchers identify immunotherapy targets in early-stage lung cancer
Lung CA seen on CXR. Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell. Researchers...
Post
Annual flu jab may pose greater risk for lung cancer patients under immunotherapy
Lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors may be at increased risk of adverse events after receiving the seasonal influenza vaccination, according to the first study measuring this effect. The results, presented today at the European Lung Cancer Conference (ELCC) 2017 in Geneva, Switzerland, offer the first hint of a possible contraindication with two...
Post
What are the stages of lung cancer?
There are two main types of lung cancer: non-small cell lung cancer and small cell lung cancer. Each has its own system of staging, a process that determines the extent to which a cancer has spread. Staging helps doctors predict outlook and develop the best possible treatment plan. Stages Both the main types of lung cancer have...
Post
Nasal swab could help diagnose lung cancer
In the case of patients with low risk of lung cancer, the current diagnostic procedure can sometimes be invasive and unnecessary. However, new research may have uncovered a less invasive, less costly way to screen these patients. New research suggests that a simple nasal swab could accurately determine whether a patient has lung cancer. A...
Post
Novartis’ drug tops chemotherapy in untreated lung cancer patients
Novartis AG said its cancer drug, Zykadia, was twice as effective as chemotherapy in slowing the progression of a rare form of lung cancer in a late-stage study. Swiss drugmaker Novartis’ logo is seen behind scaffolding at the company’s plant in the northern Swiss town of Stein in this January 27, 2015 file photo. REUTERS/Arnd...
Post
Simple blood test could show lung cancer 5 YEARS before the disease even appears on medical scans
Antibodies are produced by the immune system during the early stages The best hope for successful lung cancer treatment is to detect it early But screening patients at high-risk for antibodies could save many lives A simple blood test could allow doctors to spot signs of lung cancer five years before the disease even shows on...